The Board of the Young Academy of Europe (YAE) met at the Ludwig Maximilian University (LMU) of Munich to officially register the YAE as a charity in Germany. Registration as a charity establishes the official status of the YAE and enables it to start raising funds and receive donations, and to grow further as a community and a positive force for influencing scientific policy throughout Europe. The charity status also allows the YAE to register at the EU and to participate fully in future grants.
“The Young Academy Europe is delighted that it can now call the LMU Munich as its official home and wants to express its gratitude for making this possible”, says Mangala Srinivas, the current chair of the YAE, and member of the theme Nanomedicine. “It is also welcome that space, and some funding, can be available for all members to organise events relevant to the YAE at the LMU.”
The YAE was set up in 2012 as a bottom-up, pan-European initiative of a dynamic and innovative group of recognized European early career scientists and scholars with outspoken views about science and science policy.
Photos: YAE board members at Ludwig Maximilians Universitat Munchen coming together to see the registering of the charity. Members of the Advisory Committee, and the original founding members of the YAE, also attended.
Related news items
BRAINMODEL: precision medicine for brain disorders25 October 2021
A team of researchers from Radboudumc, VU Amsterdam and other institutes is going to look for new and better ways to heal developmental disorders in the brain.read more
How healthy is James Bond? - A flu to a kill No time to die: the pathogens surrounding secret agent 00721 October 2021
James Bond made a total of 25 films between 1962 and 2021. In all those films, secret agent 007 washed his hands only twice, even though he often stayed in not so hygienic places with considerable health risks. Radboudumc researchers examined all the health risks in the 47 countries Bond visited.read more
Surprisingly dominant cause underlying type I congenital defect of glycosylation21 October 2021
Alex Garanto, Melissa Bärenfänger, Mirian Janssen, and Dirk Lefeber published a new study, identifying a surprisingly dominant genetic cause underlying type I congenital defect of glycosylation with neuromusculoskeletal phenotypes.read more
Sensitive blood-test as a patient-friendly alternative for bone marrow-based cancer monitoring20 October 2021
Hans Jacobs and Pieter Langerhorst, theme Cancer development and immune defense, and colleagues are one step closer to implementation of personalized diagnostics for bone marrow-based cancer monitoring.read more
Register for peer coaching for RIMLS PhD candidates20 October 2021
As a PhD candidate, you are in the lead of your own learning process, but you don’t need to do this alone. Register for the peer-coaching group ‘Stay in the lead – Together’ before 11 November 2021.read more